Effect of cost-sharing for prescription medications on health outcomes in older adults: A critical review of the literature and potential implications for managed care

Consultant Pharmacist

Volumn 23, Issue 1, 2008, Pages 44-54

  Page II, Robert Lee ^a,d   Barton, Phoebe ^b   Nair, Kavita ^c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS   (United States)

^c University of Colorado Denver Anschutz Medical Campus   (United States)

^d Academic Office 1   (United States)

Author keywords

Aged; Copayments; Cost sharing

Indexed keywords

CHRONIC DISEASE; COST; ELDERLY CARE; EMERGENCY WARD; HEALTH CARE; HEALTH CARE UTILIZATION; HEALTH MAINTENANCE ORGANIZATION; HEALTH SERVICE; HOSPITAL ADMISSION; HUMAN; INSURANCE; MANAGED CARE; MANAGED CARE ORGANIZATION; MORTALITY; OUTCOME ASSESSMENT; POLICY; PRESCRIPTION; PUBLICATION; REVIEW; SOCIOECONOMICS;

EID: 38349182518     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/tcp.n.2008.44     Document Type: Review

References (43)

1. Centers for Medicare and Medicaid Services. Centers for Medicare and Medicaid Services National Health Expenditure Accounts, Historical. Available at http://www.cms.hhs.gov/NationalHealthExpendData/downloads/tables.pdf. Accessed August 1, 2008.
2. Levy RA. Prescription cost sharing: economic and health impacts, and implications for health policy. Pharmacoeconomics 1992;2:219-37.
3. Rice T, Matsuoka KY. The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniors. Med Care Res Rev 2004;61:415-52.
4. Fairman KA, Motheral BR, Henderson RR. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. Clin Ther 2003;25:3147-61.
5. Gibson TB, Ozminkowski RJ, Goetzel RZ. The effects of prescription drug cost sharing: a review of the evidence. Am J Manag Care 2005;11:730-40.
6. Kaiser Family Foundation and Health Research and Educational Trust. Prescription Drug Trends, June 2006. Available at http://www.kff.org/insurance/ 7315/sections/upload/7315Section9.pdf. Accessed August 1, 2007.
7. Tamblyn R, Laprise R, Hanley JA et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9.
8. Anis AH, Guh DP, Lacaille D et al. When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions. CMAJ 2005;173:1335-40.
9. Soumerai SB, Ross-Degnan D, Fortess EE et al. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Milbank Q 1993;71:217-52.
10. Stuart B, Grana J. Ability to pay and the decision to medicate. Med Care 1998;36:202-11.
11. Curtis LH, Ostbye T, Sendersky V et al. Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med 2004;164:1621-5.
12. Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: findings from the 1997 Medicare current beneficiary survey and the 1996 medical expenditure survey. J Am Geriatr Soc 2005; 53:438-43.
13. Hanlon JT, Schmader KE, Ruby CM et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001;49:200-9.
14. Barton PL. Chapter 19. The health services delivery system: managed care. In: Barton PL, ed. Understanding the US Health Services System. 2nd ed. Chicago, IL: Health Administration Press; 2003:421-54.
15. Buntinx F, Niclaes L, Suetens C et al. Evaluation of Charlson's comorbidity index in elderly living in nursing homes. J Clin Epidemiol 2002; 55:1144-7.
16. Keeler EB, Rolph JE. How cost sharing reduced medical spending of participants in the health insurance experiment. JAMA 1983;249:2220-7.
17. Magid DJ, Koepsell TD, Every NR et al. Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. N Engl J Med 1997;336:1722-9.
18. Manning WG, Newhouse JP, Duan N et al. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev 1987;77:251-77.
19. Newhouse JP. Consumer-directed health plans and the RAND Health Insurance Experiment. Health Aff (Millwood) 2004;23:107-13.
20. Newhouse JP, Manning WG, Morris CN et al. Some interim results from a controlled trial of cost sharing in health insurance. N Engl J Med 1981;305:1501-7.
21. Johnson RE, Goodman MJ, Hornbrook MC et al. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care 1997;35:1119-31.
22. Johnson RE, Goodman MJ, Hornbrook MC et al. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members. Health Serv Res 1997;32:103-22.
23. Motheral BR, Fairman KA. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Med Care 2001;39:1293-304.
24. Fairman KA, Motheral BR, Henderson RR. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization costs. Clin Ther 2003;25:3147-61.
25. Balkrishnan R, Byerly WG, Camacho FT et al. Effect of prescription benefit changes on medical care utilization in a Medicare HMO population. Am J Manag Care 2001;7:1093-100.
26. Christian-Herman J, Emons M, George D. Effects of generic-only drug coverage in a Medicare HMO. Health Affairs 2004; Web Exclusive: W455-W468.
27. Hsu J, Price M, Huang J et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med 2006;354:2349-59.
28. Tabmlyn R, Laprise R, Hanley JA et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-9.
29. Gabel J, Claxton G, Gil I et al. Health beneftis in 2004: four years of double-digit premium increases take their toll on coverage. Health Affairs 2004;23:200-9.
30. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing-associations with medication and medical utilization and spending and health. JAMA 2007;298:61-9.
31. Cole JA, Norman H, Weatherby LB et al. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy 2006;26:1157-64.
32. Gibson TB, Mark TL, Axelsen K et al. Impact of statin copayments on adherence and medical care utilization and expenditures. Am J Manag Care 2006;12(special issue):11-9.
33. Gibson TB, Mark TL, McGuigan KA et al. The effects of prescription drug copayments on statin adherence. Am J Manag Care 2006;12:509-17.
34. Goldman DP, Joyce GF, Karaca-Mandic P. Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy. Am J Manag Care 2006;12:21-8.
35. Mahoney JJ. Reducing patient drug acquisition costs can lower diabetes health claims. Am J Manag Care 2005;11:170-6.
36. Soumerai SB, McLaughlin TJ, Ross-Degnan D et al. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994;331:650-5.
37. Pilote L, Beck C, Richard H et al. The effects of cost-sharing on essential drug prescriptions, utilization of medical care, and outcomes alter acute myocardial infarction in elderly patients. CMAJ 2002;167:246-52.
38. Anis AH, Guh DP, Lacaille D et al. When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions, and filling of prescriptions. CMAJ 2005;173:1335-40.
39. Centers for Disease Control and Prevention. National Center for Health Statistics. Trends in Health and Aging. Available at http://www.cdc.gov/ nchs/agingact.htm. Accessed August 1, 2008.
40. Kaiser Family Foundation and Health Research and Educational Trust. The Medicare Fact Sheet-Medicare Prescription Drug Benefit, November 2006. Available at http://www.kff.org/medicarc/upload/7044-05.pdf. Accessed August 1, 2007.
41. Centers for Medicare and Medicaid Services. Part D Enrollment Data. Total Part D Beneficiaries Enrollment, June 11, 2006. Available at http://www.cms.hhs.gov/PrescriptionDrugCovGenIn/02_EnrollmentData .asp#TopOfPage. Accessed August 1, 2007.
42. Centers for Medicare and Medicaid Services. Part D Enrollment Data. Medicare Advantage Plans with Medicare Prescription Drug Coverage (MA-PDs) by Total Enrollment in Parent Organization. Available at http://www.cms.hhs.gov/ PrescriptionDrugCovGenIn/02_EnrollmentData.asp#TopOfPage. Accessed August 1, 2007.
43. Robinson J. From managed care to consumer health insurance: the fall and rise of Aetna. Health Affairs 2004;23:43-55.